Inside Mount Sinai

In this issue:

  • A CoreValve device pioneered by David Adams, MD, is associated with a higher survival rate than open heart surgery. Dr. Adams’s study appeared last week in The New England Journal of Medicine and was introduced at the American College of Cardiology’s 2014 Scientific Sessions.

  • Ming-Ming Zhou, PhD, and a team of researchers have located a drug target for a potential new treatment for triple negative breast cancer.

  • The Mount Sinai Health System recently opened the first Observation Unit in New York City, which serves emergency department patients who do not meet inpatient admission criteria but need additional evaluation.

  • The Recanati/Miller Transplantation Institute recently opened a new outpatient center named after donor Joanna Adler, a former pediatric patient of Dr. Leona Kim-Schluger’s, who helped fund the renovation.

View the PDF